быстрая доставка ~4 недели
Размер
- 100 μg
- 1000 μg
- 500 μg
Recombinant Human BTLA Protein (RP02018)
- Описание
-
Overview
Product name Recombinant Human BTLA Protein Catalog No. RP02018 Description Recombinant Human PD-L1 Protein is produced by mammalian expression system. The target protein is expressed with sequence (Met1-Ser150) of human BTLA (Accession #Q7Z6A9) fused with a 6xHis, Avi tag at the C-terminus. Bio-Activity Immobilized Human BTLA at 0.5 μg/mL (100 μL/well), dose response curve for Human HVEM, Fc Tag with the EC50 of 0.1 μg/mL determined by ELISA. Purity > 95% by SDS-PAGE. Endotoxin < 0.1 EU/μg of the protein by LAL method. Formulation Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4.Contact us for customized product form or formulation. Species Human Background
B- and T-lymphocyte attenuator (BTLA; CD272) is a 35 kDa type I transmembrane glycoprotein in the CD28 family of T cell costimulatory molecules. BTLA is a inhibitory receptor on lymphocytes that negatively regulates antigen receptor signaling via PTPN6/SHP-1 and PTPN11/SHP-2 . BTLA may interact in cis (on the same cell) or in trans (on other cells) with TNFRSF14.Product information
Synonym BTLA1; CD272 Expression Host HEK293 cells Tag C-His&Avi Swiss-Prot Gene ID Usage guide
Storage Store the lyophilized protein at -20°C to -80 °C for long term.
After reconstitution, the protein solution is stable at -20 °C for 3 months, at 2-8 °C for up to 1 week.Reconstitution Reconstitute to a concentration of 0.1-0.5 mg/mL in sterile distilled water. * For research use only. Not for therapeutic or diagnostic purposes.
Product Protocols